Institutional Ownership Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS). We have compiled data on the 98 institutions that hold shares in the stock, with a total of 87.6 Million shares, which have been reported (via 13F filing form) to have a value of $171 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
509,350
shares
|
$937,204
0.0% of portfolio
|
Q2 2025
Reduced 62.29%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
498,721
shares
|
$917,646
0.0% of portfolio
|
Q1 2025
Added 464.68%
|
|
|
Stonepine Capital Management, LLC
Bend, OR |
Aug 13, 2025 Q2 2025 |
491,300
shares
|
$903,992
0.68% of portfolio
|
Q2 2025
Reduced 6.92%
|
|
|
Cantor Fitzgerald, L. P.
New York, NY |
Aug 14, 2025 Q2 2025 |
451,120
shares
|
$830,060
0.0% of portfolio
|
Q2 2025
Reduced 35.14%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Aug 14, 2025 Q2 2025 |
443,319
shares
|
$815,706
0.02% of portfolio
|
Q2 2025
Added 53.55%
|
|
|
Aisling Capital Management LP
New York, NY |
Aug 13, 2025 Q2 2025 |
434,455
shares
|
$799,397
0.17% of portfolio
|
Q4 2022
Reduced 31.52%
|
|
|
Squarepoint Ops LLC
New York, NY |
Aug 27, 2025 Q2 2025 |
390,583
shares
|
$718,672
0.0% of portfolio
|
Q2 2025
Added 11.94%
|
|
|
High Tower Advisors, LLC
Chicago, IL |
Aug 11, 2025 Q2 2025 |
321,817
shares
|
$592,143
0.0% of portfolio
|
Q2 2025
Added 1.82%
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Aug 14, 2025 Q2 2025 |
277,259
shares
|
$510,156
0.0% of portfolio
|
Q2 2025
Added 10.55%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
261,298
shares
|
$480,788
0.0% of portfolio
|
Q1 2025
Reduced 87.34%
|
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
237,830
shares
|
$437,607
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
207,273
shares
|
$381,382
0.0% of portfolio
|
Q2 2025
Reduced 41.59%
|
|
|
Assenagon Asset Management S.A.
|
Jul 11, 2025 Q2 2025 |
184,585
shares
|
$339,636
0.0% of portfolio
|
Q2 2025
Reduced 72.92%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
166,367
shares
|
$306,115
0.0% of portfolio
|
Q2 2025
Added 35.15%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
156,572
shares
|
$288,092
0.0% of portfolio
|
Q2 2025
Reduced 71.84%
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
156,337
shares
|
$287,660
0.0% of portfolio
|
Q2 2025
Added 31.37%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
153,172
shares
|
$281,836
0.0% of portfolio
|
Q2 2025
Added 107.01%
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
135,329
shares
|
$249,005
0.0% of portfolio
|
Q2 2025
Added 137.09%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
121,147
shares
|
$222,910
0.0% of portfolio
|
Q2 2025
Reduced 91.23%
|
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
84,965
shares
|
$156,335
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
72,595
shares
|
$133,574
0.0% of portfolio
|
Q2 2025
Reduced 56.7%
|
|
|
New York State Common Retirement Fund
|
Aug 13, 2025 Q2 2025 |
64,200
shares
|
$118,128
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Wells Fargo & Company
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
62,840
shares
|
$115,625
0.0% of portfolio
|
Q2 2025
Added 1269.06%
|
|
|
Met Life Investment Management, LLC
Whippany, NJ |
Aug 13, 2025 Q2 2025 |
56,344
shares
|
$103,672
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Sg Americas Securities, LLC
|
Aug 08, 2025 Q2 2025 |
53,359
shares
|
$98,180
0.0% of portfolio
|
Q2 2025
Reduced 21.45%
|